Business Description
Canton Strategic Holdings Inc. is a New Jersey-based company founded in 2017 that works to bring blockchain technology into mainstream financial institutions, primarily through its involvement with Canton Coin and the broader Canton network. Alongside this, the company develops medical treatments, including a dissolving film drug designed to counter respiratory and nervous system emergencies in military and emergency response settings, and a pill-form version of a medication traditionally given by IV drip for inflammatory conditions. The company operated under the name Tharimmune Inc. until early 2026.
